Tài liệu tham khảo |
Loại |
Chi tiết |
1. Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide.Arca M, Fardet L, Galicier L, Rivière S, Marzac C, Aumont C, Lambotte O, Coppo Br J Haematol. 2015 Jan;168(1):63-8. Epub 2014 Aug 26 |
Khác |
|
2. Variable CD52 expression in mature T cell and NK cell malignancies: implications for alemtuzumab therapy.Jiang L, Yuan CM, Hubacheck J, Janik JE, Wilson W, Morris JC, Jasper GA, Stetler-Stevenson MBr J Haematol. 2009 Apr;145(2):173-9. Epub 2009 Feb 19 |
Khác |
|
3. De Armas R, Sindou P, Gelot A, Routon MC, Ponsot G, Vallat JM,(2004), Demyelinating peripheral neuropathy associated with hemophagocytic lymphohistiocytosis, An immuno-electron microscopic study,Acta Neuropathol, 2004 Oct;108(4):341-4, Epub 2004 Jul 9 |
Khác |
|
4. Imashuku S et al (2002),Low natural killer activity and central nervous system disease as a high-risk prognostic indicator in young patients with Hemophagocytic Lymphohistiocytosis, American Cancer Society, 2002, 3023-3031. 4.Ih-Jen Su (2008),Perpective on the pathogenesis and therapy of Hemophagocytic syndrome, J Formo Med Assocciation ,2008, 107:277-280 |
Khác |
|
5. Ishii E et al (2007),Nationwide survey of hemophagocytic lymphohistiocytosis in Japan,Int J Hematology,2007 Jul,86(1):58-65. 16 6. Jan-Inge Henter et al (2007), HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis, Pediatric BloodCancer,2007 Feb;48(2):124-31 |
Khác |
|
8. Lee JS, Kang JH, Lee GK, Park HJ (2005), Successful treatment of Epstein-Barrvirus associated hemophagocytic lymphohistiocytosis with HLH- 94 protocol, J Korean Med sci, 2005 Apr;20(2) :209-14 |
Khác |
|
9. Lee WI, Chen SH, Hung IJ, Yang CP, Jaing TH, Chen CJ, Li SP, Huang JL( 2009),Clinical aspects, immunologic assessment, and genetic analysis in Taiwanese children with hemophagocytic lymphohistiocytosis,Pediatr Infect Dis J, 2009 Jan;28(1):30-4 |
Khác |
|
10. Tadokoro R, Okumura A, Nakazawa T, Hara S, Yamakawa Y, Kamata A, Kinoshita K, Obinata K, Shimizu T, Acute encephalopathy with biphasic seizures and late reduced diffusion associated with hemophagocytic syndrome Acute encephalopathy with biphasic seizures and late reduced diffusion associated with hemophagocytic syndrome,Brain Dev, 2010 Jun;32(6):477-81, Epub 2009 Jun 24 |
Khác |
|
11. Tang YM, (2011),Advances in hemophagocytic lymphohistiocytosis: pathogenesis, early diagnosis/differential diagnosis, and treatment, Scientific World Journal 2011 Mar 22;11:697-708 |
Khác |
|
12. Veerakul G et al (2002),Secondary hemophagocytic lymphohistiocytosis in children: an analysis of etiology and outcome, J Med Association Thai, 2002 Aug; 85 Suppl 2:S 530-41 |
Khác |
|
13. Treatment of hemophagocytic lymphohistiocytosis with cyclophosphamide, vincristine, and prednisone.Hu Y, Xu J, Wang L, Li J, Qiu H, Zhang Swiss Med Wkly. 2012;142:w13512 |
Khác |
|
14. Unremitting pyrexia, pancytopenia, hepatosplenomegaly, and extreme hyperferritinemia.Gill H, Liu S, Ip A, Loong F, Lee EY, Leung RY, Lau CS, Ip WK, Tam S, Kwong YL;Am J Hematol. 2013;88(7):626 |
Khác |
|
15. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis.Parikh SA, Kapoor P, Letendre L, Kumar S, Wolanskyj APMayo Clin Proc. 2014;89(4):484 |
Khác |
|